← Leaderboards
Penelope Hogarth
Oregon Health And Science University
$2,643,080
Attributed
$2,643,080
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $509.5K · FY2005–23$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,643,080 · 4
By mechanism
R01$2,210,842 · 1
M01$432,238 · 3
Top collaborators
No co-investigators on record.
Most similar at Oregon Health And Science University
Same institution · by research overlap
- Susan J Hayflick$5,778,640
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchDisabilityCell Culture TechniquesDisease-Causing MutationDefectDesignAnabolismAdultBiologicalAdverse EventCostBrainAdherenceCategoriesActive MethodCell TransformationCharacteristicsChildClinicDisease ManagementCoenzyme ACollaborationsAffectDose
Grant awards (11)
A phase 2 study of a vitamin metabolite for PKAN$425,179
R01 · FY2023 · HD · contact PI
A phase 2 study of a vitamin metabolite for PKAN$411,268
R01 · FY2022 · HD · contact PI
A phase 2 study of a vitamin metabolite for PKAN$426,551
R01 · FY2021 · HD · contact PI
A phase 2 study of a vitamin metabolite for PKAN$438,361
R01 · FY2020 · HD · contact PI
A phase 2 study of a vitamin metabolite for PKAN$509,483
R01 · FY2019 · HD · contact PI
DBS COOPERATIVE STUDY$126,850
M01 · FY2005 · RR
A DOSE-FINDING STUDY OF SBP-11 (SODIUM PHENYLBUTYRATE) IN HUNTINGTON'S DISEASE$50,988
M01 · FY2005 · RR
A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, TWO PERIOD CROSSOVER PILOT STUDY$10,571
M01 · FY2005 · RR
DBS Cooperative Study$174,774
M01 · FY2004 · RR
A Randomized, Placebo-Controlled, Double-Blind, Two Period Crossover Pilot Study$47,055
M01 · FY2004 · RR
A dose-finding study of SBP-11 (sodium phenylbutyrate) in Huntington's disease$22,000
M01 · FY2004 · RR